Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1618
This examiner grants 46% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18552760 | DIAGNOSTIC METHODS OF PROSTATE CANCER | Non-Final OA | NOVARTIS AG |
| 17771142 | POLYMERIC NANOPARTICLES FOR INTRACELLULAR PROTEIN DELIVERY | Final Rejection | The Johns Hopkins University |
| 17781731 | CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY | Final Rejection | UNIVERSITÄT ZÜRICH |
| 17234669 | Multi-Functional Infrared-Emitting Composites | Non-Final OA | Rutgers, The State University of New Jersey |
| 17064352 | INORGANIC NANOCAGES, AND METHODS OF MAKING AND USING SAME | Final Rejection | Cornell University |
| 18282705 | ULTRASMALL GADOLINIUM-INTERCALATED CARBON DOTS AS A RADIOSENSITIZING AGENT FOR CANCER | Non-Final OA | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. |
| 17579967 | C60 GLUTATHIONE DOPA AND METHODS | Non-Final OA | Carbon 60 (Zhejiang) Pharmaceutical Technology Co., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy